The U.S. Food and Drug Administration (FDA) will host a free, hybrid public listening session on recall modernization on September 29, 2023. The listening session will provide an opportunity for stakeholders to share information and feedback about topics related to recall modernization for FDA-regulated products.
In a new video and infographic, the U.S. Food and Drug Administration (FDA) has provided an overview of the traceback process used during foodborne illness outbreaks to investigate a food’s path through the supply chain.
The U.S. Food and Drug Administration (FDA) has announced the fiscal year (FY) 2024 user fee rates for the Voluntary Qualified Importer Program (VQIP) and the Accredited Third-Party Certification Program (TPP). Both are programs under FDA’s Food Safety Modernization Act (FSMA).
In this episode of Food Safety Matters, we are joined by Sarah Gallo, Vice President of Product Policy at the Consumer Brands Association (CBA). Sarah outlines CBA’s efforts to push for modernization at FDA with regard to inspections, recalls, labeling guidance development, and chemicals management in food packaging. She also shares CBA’s perspective on the proposed reorganization of FDA’s Human Foods Program. Also featured is a conversation with Dr. Emilio Esteban, Under Secretary for Food Safety at the USDA's Office of Food Safety, that was recorded at IAFP 2023 in Toronto, Canada.
Through a voluntary pilot program, the U.S. Food and Drug Administration (FDA) found four major third-party industry auditing standards for food safety to be in alignment with both the Preventive Controls for Human Foods Rule and the Produce Safety Rule, which are FDA regulations that were issued as part of Food Safety Modernization Act (FSMA) implementation.
However, FDA and industry groups disagree with WHO's determination.
The World Health Organization (WHO) has officially declared popular artificial sweetener aspartame as “possibly carcinogenic to humans," although the acceptable daily intake of 40 milligrams mg/kg of body weight remains unchanged. Additionally, FDA and industry groups disagree with WHO's determination.
The U.S. Food and Drug Administration has reissued two temporary guidances originally published during the COVID-19 public health emergency (PHE) for certain regulatory requirements that involve onsite visits abroad under the Food Safety Modernization Act (FSMA).
Following a May 2023 announcement of a new framework for systematic post-market reassessment for chemicals used in foods, the U.S. Food and Drug Administration (FDA) has released a public inventory of certain food ingredients and additives determined to have unsafe uses in food because they are unapproved, as well as lists of select chemicals currently under the agency’s review. FDA also shared insights about the agency’s work to enhance the assessment of ingredients in foods on the market.
The U.S. Food and Drug Administration’s (FDA’s) Center for Food Safety and Applied Nutrition (CFSAN) and Office of Food Policy and Response (OFPR) have released an updated list of draft and final guidance topics that are a priority for the FDA Foods Program to complete during 2023. The list updates the guidance agenda released in February 2023 and focuses on Level 1 draft and final guidances.
